These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


195 related items for PubMed ID: 8497058

  • 21. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules.
    Shirai M, Pendleton CD, Berzofsky JA.
    J Immunol; 1992 Mar 15; 148(6):1657-67. PubMed ID: 1371784
    [Abstract] [Full Text] [Related]

  • 22. Replication-deficient recombinant adenoviruses expressing the human immunodeficiency virus Env antigen can induce both humoral and CTL immune responses in mice.
    Bruce CB, Akrigg A, Sharpe SA, Hanke T, Wilkinson GWG, Cranage MP.
    J Gen Virol; 1999 Oct 15; 80 ( Pt 10)():2621-2628. PubMed ID: 10573155
    [Abstract] [Full Text] [Related]

  • 23. Detection of primary cytotoxic T lymphocytes specific for the envelope glycoprotein of HIV-1 by deletion of the env amino-terminal signal sequence.
    McChesney M, Tanneau F, Regnault A, Sansonetti P, Montagnier L, Kieny MP, Rivière Y.
    Eur J Immunol; 1990 Jan 15; 20(1):215-20. PubMed ID: 2106442
    [Abstract] [Full Text] [Related]

  • 24. Effect of the V3 loop deletion of envelope glycoprotein on cellular responses and protection against challenge with recombinant vaccinia virus expressing gp160 of primary human immunodeficiency virus type 1 isolates.
    Kiszka I, Kmieciak D, Gzyl J, Naito T, Bolesta E, Sieron A, Singh SP, Srinivasan A, Trinchieri G, Kaneko Y, Kozbor D.
    J Virol; 2002 May 15; 76(9):4222-32. PubMed ID: 11932387
    [Abstract] [Full Text] [Related]

  • 25. Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variation.
    Johnson RP, Trocha A, Buchanan TM, Walker BD.
    J Exp Med; 1992 Apr 01; 175(4):961-71. PubMed ID: 1372650
    [Abstract] [Full Text] [Related]

  • 26. Preferential V beta usage by cytotoxic T cells cross-reactive between two epitopes of HIV-1 gp160 and degenerate in class I MHC restriction.
    Shirai M, Vacchio MS, Hodes RJ, Berzofsky JA.
    J Immunol; 1993 Aug 15; 151(4):2283-95. PubMed ID: 7688397
    [Abstract] [Full Text] [Related]

  • 27. Cross-reactions between the cytotoxic T-lymphocyte responses of human immunodeficiency virus-infected African and European patients.
    Durali D, Morvan J, Letourneur F, Schmitt D, Guegan N, Dalod M, Saragosti S, Sicard D, Levy JP, Gomard E.
    J Virol; 1998 May 15; 72(5):3547-53. PubMed ID: 9557634
    [Abstract] [Full Text] [Related]

  • 28. Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes.
    Yang OO, Kalams SA, Rosenzweig M, Trocha A, Jones N, Koziel M, Walker BD, Johnson RP.
    J Virol; 1996 Sep 15; 70(9):5799-806. PubMed ID: 8709196
    [Abstract] [Full Text] [Related]

  • 29. Envelope protein and p18(IIIB) peptide recognized by cytotoxic T lymphocytes from humans immunized with human immunodeficiency virus envelope.
    Achour A, Picard O, Mbika JP, Willer A, Snart R, Bizzini B, Carelli C, Burny A, Zagury D.
    Vaccine; 1993 Sep 15; 11(7):609-701. PubMed ID: 7688170
    [Abstract] [Full Text] [Related]

  • 30. Molecular analysis of presentation by HLA-A2.1 of a promiscuously binding V3 loop peptide from the HIV-envelope protein to human cytotoxic T lymphocytes.
    Alexander-Miller MA, Parker KC, Tsukui T, Pendleton CD, Coligan JE, Berzofsky JA.
    Int Immunol; 1996 May 15; 8(5):641-9. PubMed ID: 8671651
    [Abstract] [Full Text] [Related]

  • 31. Induction of CD8+ cytotoxic T lymphocytes by immunization with syngeneic irradiated HIV-1 envelope derived peptide-pulsed dendritic cells.
    Takahashi H, Nakagawa Y, Yokomuro K, Berzofsky JA.
    Int Immunol; 1993 Aug 15; 5(8):849-57. PubMed ID: 8398980
    [Abstract] [Full Text] [Related]

  • 32. Immunization of mice with lipopeptides bypasses the prerequisite for adjuvant. Immune response of BALB/c mice to human immunodeficiency virus envelope glycoprotein.
    Martinon F, Gras-Masse H, Boutillon C, Chirat F, Deprez B, Guillet JG, Gomard E, Tartar A, Levy JP.
    J Immunol; 1992 Nov 15; 149(10):3416-22. PubMed ID: 1385524
    [Abstract] [Full Text] [Related]

  • 33. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response.
    Nahill SR, Welsh RM.
    J Exp Med; 1993 Feb 01; 177(2):317-27. PubMed ID: 8093891
    [Abstract] [Full Text] [Related]

  • 34. Mutation of human immunodeficiency virus type 1 at amino acid 585 on gp41 results in loss of killing by CD8+ A24-restricted cytotoxic T lymphocytes.
    Dai LC, West K, Littaua R, Takahashi K, Ennis FA.
    J Virol; 1992 May 01; 66(5):3151-4. PubMed ID: 1373204
    [Abstract] [Full Text] [Related]

  • 35. Virus-specific cytotoxic T-lymphocytes in HIV-2-infected cynomolgus macaques.
    Voss G, Nick S, Otteken A, Lüke W, Stahl-Hennig C, Hunsmann G.
    AIDS; 1992 Oct 01; 6(10):1077-83. PubMed ID: 1466839
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.